Globally active firm producing and distributing reagents for in-vitro molecular diagnostic testing seeks to acquire a controlling share in a company with successful operations in the development and production of biotechnologies and innovative solutions for modern clinical diagnostic needs.
Following the initial contact request, the applicant company will be asked to prepare a detailed information memorandum in English.

We are a team of French researchers that grew out of a university spin-off holding several patents in the field of molecular medicine. We have recently identified and isolated a gene that inhibits sensitivity to chemotherapy treatments of the intestinal tract; taking advantage of therapeutic magnetic nanoparticles, we have developed a diagnostic kit using this technology.
In order to enhance the value of this scientific finding, we are interested in productive engagement with a venture capitalist specialized in this field with an eye to collaboratively evaluating the best prospects for economic development.